AZURITY PHARMACEUTICALS, INC. v. BIONPHARMA INC. , No. 21-1926 (Fed. Cir. 2022)

Annotate this Case

Download PDF

Case: 21-1926 Document: 48 Page: 1 Filed: 03/09/2022 NOTE: This disposition is nonprecedential. United States Court of Appeals for the Federal Circuit ______________________ AZURITY PHARMACEUTICALS, INC., Plaintiff-Appellant v. BIONPHARMA INC., Defendant-Appellee ______________________ 2021-1926, 2021-1927 ______________________ Appeals from the United States District Court for the District of Delaware in Nos. 1:18-cv-01962-LPS, 1:19cv-01067-LPS, Judge Leonard P. Stark. ______________________ JUDGMENT ______________________ RICHARD TORCZON, Wilson, Sonsini, Goodrich & Rosati, PC, Washington, DC, argued for plaintiff-appellant. Also represented by TY WILLIAM CALLAHAN, GRANVILLE CLAYTON KAUFMAN, Los Angeles, CA; WENDY L. DEVINE, NICHOLAS SYLVESTER HALKOWSKI, KRISTINA M. HANSON, San Francisco, CA; NATALIE J. MORGAN, San Diego, CA. ANDREW M. ALUL, Taft, Stettinius & Hollister, LLP, Chicago, IL, argued for defendant-appellee. Also represented by ROSHAN SHRESTHA. Case: 21-1926 Document: 48 Page: 2 Filed: 03/09/2022 ______________________ THIS CAUSE having been heard and considered, it is ORDERED and ADJUDGED: PER CURIAM (NEWMAN, CLEVENGER, and STOLL, Circuit Judges). AFFIRMED. See Fed. Cir. R. 36. ENTERED BY ORDER OF THE COURT March 9, 2022 Date /s/ Peter R. Marksteiner Peter R. Marksteiner Clerk of Court

Some case metadata and case summaries were written with the help of AI, which can produce inaccuracies. You should read the full case before relying on it for legal research purposes.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.